Search Results - "Sideri, M"

Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women by Minig, L., Franchi, D., Boveri, S., Casadio, C., Bocciolone, L., Sideri, M.

“…To test the efficacy of levonorgestrel-release intrauterine device (LNG-IUD) plus gonadotropin-releasing hormone (GnRH) for treating women aged <40 years with…”
Get full text

I337 VULVAR INTRAEPITHELIAL NEOPLASIA – HOW TO CLASSIFY IT CORRECTLY? by Sideri, M.

Get full text

I336 THE UTILITY OF COLPOSCOPY IN THE MANAGEMENT OF WOMEN WITH ABNORMAL SCREENING TESTS by Sideri, M.

Get full text

Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter by Giorgi Rossi, P, Fortunato, C, Barbarino, P, Boveri, S, Caroli, S, Del Mistro, A, Ferro, A, Giammaria, C, Manfredi, M, Moretto, T, Pasquini, A, Sideri, M, Tufi, M C, Cogo, C, Altobelli, E

“…Background: We performed a multicentre randomised controlled trial to evaluate the effect on participation in organised screening programmes of a self-sampling…”
Get full text

Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome by Sandri, M.T, Bottari, F, Franchi, D, Boveri, S, Candiani, M, Ronzoni, S, Peiretti, M, Radice, D, Passerini, R, Sideri, M

“…Abstract Objective The quality of first surgery is one of the most important prognostic factors in ovarian cancer patients. Pre-surgical distinction of benign…”
Get full text

Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions by Bottari, F, Sideri, M, Gulmini, C, Igidbashian, S, Tricca, A, Casadio, C, Carinelli, S, Boveri, S, Ejegod, D, Bonde, J, Sandri, M T

“…Analytical and clinical performance validation is essential before introduction of a new human papillomavirus (HPV) assay into clinical practice. This study…”
Get full text

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study by DeCensi, A., Bonanni, B., Maisonneuve, P., Serrano, D., Omodei, U., Varricchio, C., Cazzaniga, M., Lazzeroni, M., Rotmensz, N., Santillo, B., Sideri, M., Cassano, E., Belloni, C., Muraca, M., Segnan, N., Masullo, P., Costa, A., Monti, N., Vella, A., Bisanti, L., D'Aiuto, G., Veronesi, U.

“…Postmenopausal hormone replacement therapy (HRT) relieves menopausal symptoms and may decrease mortality in recently postmenopausal women, but increases breast…”
Get full text

Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology by Origoni, M., Carminati, G., Rolla, S., Clementi, M., Sideri, M., Sandri, M. T., Candiani, M.

“…Human papillomavirus (HPV) testing is more sensitive and has higher negative predictive value (NPV) than the Pap test for the detection of cervical…”
Get full text

HPV self-sampling in CIN2+ detection: sensitivity and specificity of different RLU cut-off of HC2 in specimens from 786 women by Bottari, F, Igidbashian, S, Boveri, S, Tricca, A, Gulmini, C, Sesia, M, Spolti, N, Sideri, M, Landoni, F, Sandri, M T

“…Mortality for cervical cancer varies between the different regions of the world, with high rates in low-income countries where screening programmes are not…”
Get more information

"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3 by Origoni, M, Carminati, G, Sideri, M, Clementi, M, Rolla, S, Candiani, M

“…The correlation between high-risk HPV-DNA viral load, expressed as relative light units (RLU) values obtained from the Hybrid Capture 2 (HC2) test, and the…”
Get more information

Sentinel node biopsy in early vulvar cancer by DE CICCO, C, SIDERI, M, PAGANELLI, G, BARTOLOMEL, M, GRANA, C, CREMONESI, M, FIORENZA, M, MAGGIONI, A, BOCCIOLONE, L, MANGIONI, C, COLOMBO, N

“…Lymph node pathologic status is the most important prognostic factor in vulvar cancer; however, complete inguinofemoral node dissection is associated with…”
Get full text

HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice by Origoni, M, Cristoforoni, P, Costa, S, Mariani, L, Scirpa, P, Lorincz, A, Sideri, M

“…The large amount of literature published over the last two decades on human papillomavirus (HPV)-DNA testing has definitely demonstrated the association…”
Get full text

P1088 A suggested modification to FIGO stage III vulvar cancer by Rouzier, R., Preti, M., Sideri, M., Frankman, O., Paniel, B., Jones, R.

Get full text

OC131: Ultrasonographic diagnosis and longitudinal follow‐up of recurrences after conservative surgery for Borderline Ovarian tumors by Franchi, D., Boveri, S., Testa, A. C., Colombo, N., Sideri, M.

Get full text

Blind spot enlargement: A differential diagnosis challenge by Karamaounas, Aristotelis, Sideri, Anna M, Tsiogka, Anastasia, Georgiou, Iordanis, Kourkoutas, Dimitrios, Petrou, Petros

“…A 39-year-old woman, without any systemic or ocular history, presented with a paracentral scotoma in her right eye with normal visual acuity. Humphrey's visual…”
Get full text

Evaluation of CO2 Laser Excision or Vaporization for the Treatment of Vulvar Intraepithelial Neoplasia by Sideri, M., Spinaci, L., Spolti, N., Schettino, F.

“…Objective. Ourobjective was to evaluate the results of laser surgery in patients with vulvar intraepithelial neoplasia (VIN). Methods. From January 1990 to…”
Get full text

OC226: Ultrasonographic detection of recurrence after conservative surgery for borderline ovarian tumors by Franchi, D., Boveri, S., Pittelli, M. R., Colombo, N., Sideri, M.

Get full text

OC157: Ovarian histoscanning, a new device to enhance ultrasound‐based clinical assessment of pelvic masses by Franchi, D., Di Pace, R., Boveri, S., Nir, D., Maggioni, A., Sideri, M.

Get full text

Topical testosterone in the treatment of vulvar lichen sclerosus by Sideri, M, Origoni, M, Spinaci, L, Ferrari, A

“…Comparison between 2% testosterone propionate and petrolatum ointment in the treatment of vulvar lichen sclerosus in a randomized, double-blind, controlled…”
Get more information

Resource use and cost analysis of managing abnormal Pap smears: a retrospective study in five countries by Rash, B, Martin-Hirsch, P, Schneider, A, Sideri, M, Tan, J, Torné, A, Standaert, B

“…To evaluate and compare treatment patterns and related resource use and costs in women with abnormal cervical smears in five countries. Data from patient…”
Get more information